An aryl hydrocarbon receptor agonist amplifies the mitogenic actions of estradiol in granulosa cells: Evidence of involvement of the cognate receptors

Biology of Reproduction

Volumn 74, Issue 2, 2006, Pages 417-426

  Bussmann, Ursula A ^a   Bussmann, Leonardo E ^a   Barañao, J Lino ^a,b,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c NONE   (Argentina)

Author keywords

Estradiol; Estradiol receptor; Granulosa cells; Ovary; Toxicology

Indexed keywords

ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; CATECHOL ESTROGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; OXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ESTROGEN METABOLISM; FEMALE; GENETIC TRANSCRIPTION; GRANULOSA CELL; MITOGENESIS; NONHUMAN; OVARY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZOFLAVONES; BETA-NAPHTHOFLAVONE; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; DNA; DRUG SYNERGISM; ESTRADIOL; ESTROGENS, CATECHOL; FEMALE; FOLLICLE STIMULATING HORMONE; GRANULOSA CELLS; MITOGENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

ANIMALIA;

EID: 31044444242     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.105.043901     Document Type: Article

References (68)

1. Hahn ME. The aryl hydrocarbon receptor: a comparative perspective. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998; 121:23-53.
2. Butler RA, Kelley ML, Powell WH, Hahn ME, Van Beneden RJ. An aryl hydrocarbon receptor (AHR) homologue from the soft-shell clam, Mya arenaria: evidence that invertebrate AHR homologues lack 2,3,7,8-tetrachlorodibenzo-p- dioxin and beta-naphthoflavone binding. Gene 2001; 278:223-234.
3. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995; 35:307-340.
4. Safe SH. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther 1995; 67:247-281.
5. Schmidt JV, Bradfield CA. Ah receptor signaling pathways. Annu Rev Cell Dev Biol 1996; 12:55-89.
6. Rushmore TH, Kong AN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 2002; 5:481-490.
7. Gonzales FK, Fernandez-Salguero P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 1998; 26:1194-1198.
8. Safe S, Wang F, Porter W, Duan R, McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett 1998; 102-103:343-347.
9. Porter W, Safe S. Estrogenic and antiestrogenic compounds. In: Puga A, Wallace KB, (eds.), Molecular Biology Approaches to Toxicology. Fairfax, VA: Techbooks; 267-283.
10. Wormke M, Castro-Rivera E, Ichen C, Safe S. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. J Steroid Biochem Molec Biol 2000; 72:197-207.
11. Safe S. Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 2001; 120:1-7.
12. Crawford RB, Holsapple MP, Kaminski N. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Mol Pharmacol 1997; 52:921-927.
13. Chang C, Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 1998; 18:525-535.
14. Singh SS, Hord NG, Predew GH. Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. Arch Biochem Biophys 1996; 329:47-55.
15. Komura K, Hayashi S, Makino I, Poellinger L, Tanaka H. Aryl hydrocarbon receptor/dioxin receptor in human monocytes and macrophages. Mol Cell Biochem 2001; 226:107-118.
16. Peters JM, Wiley LM. Evidence that murine preimplantation embryos express aryl hydrocarbon receptor. Toxicol Appl Pharmacol 1995; 134:214-221.
17. Puga A, Xia Y, Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 2002; 141:117-130.
18. Robles R, Morita Y, Mann KK, Perez GI, Yang S, Matikainen T, Sherr DH, Tilly JL. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology 2000; 141:450-453.
19. Benedict JC, Lin TM, Loeffler IK, Peterson RE, Flaws JA. Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol Sci 2000; 56:382-388.
20. Benedict JC, Miller KP, Lin TM, Greenfeld C, Babus JK, Peterson RE, Faws JA. Aryl hydrocarbon receptor regulates growth, but not atresia, of mouse preantral and antral follicles. Biol Reprod 2003; 68:1511-1517.
21. Abbott BD, Schmid JE, Pitt JA, Buckalew AR, Wood CR, Geld GA, Diliberto JJ. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol Appl Pharmacol 1999; 155:2-70.
22. Gasiewicz TA, Rucci G. Alpha-naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol Pharmacol 1991; 40:607-612.
23. Merchant M, Krishnan V, Safe S. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol Appl Pharmacol 1993; 120:179-185.
24. Merchant M, Safe S. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8- trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct. Biochem Pharmacol 1995; 50:663-668.
25. Brauze D, Crow JS, Malejka-Giganti D. Modulation by beta-naphthoflavone of ovarian hormone dependent responses in rat uterus and liver in vivo. Can J Physiol Pharmacol 1997; 75:1022-1029.
26. Navas JM, Segner H. Antiestrogenicity of beta-naphthoflavone and PAHs in cultured rainbow trout hepatocytes: evidence for a role of the arylhydrocarbon receptor. Aquat Toxicol 2000; 51:79-92.
27. Huang P, Ceccatelli S, Hakansson H, Grandison L, Rannug A. Constitutive and TCDD-induced expression of Ah receptor-responsive genes in the pituitary. Neurotoxicology 2002; 23:783-793.
28. Dong W, Teraoka H, Yamazaki K, Tsukiyama S, Imani S, Imagawa T, Stegeman JJ, Peterson RE, Hiraga T. 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: local circulation failure in the dorsal midbrain is associated with increased apoptosis. Toxicol Sci 2002; 69:191-201.
29. Henry EC, Gasiewicz TA. Agonist but not antagonist ligands induce conformational change in the mouse aryl hydrocarbon receptor as detected by partial proteolysis. Mol Pharmacol 2003; 63:392-400.
30. Granberg L, Ostergren A, Brandt I, Brittebo EB. CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a) anthracene in endothelial cells. Drug Metab Dispos 2003; 31:259-265.
31. Bley MA, Saragüeta PE, Barañao JL. Concerted stimulation of rat granulosa cell deoxyribonucleic acid synthesis by sex steroids and follicle-stimulating hormone. J Steroid Biochem Mol Biol 1997; 62:11-19.
32. Bley MA, Simón JC, Saragüeta PE, Barañao JL. Hormonal regulation of rat granulosa cell deoxyribonucleic acid synthesis: effects of estrogens. Biol Reprod 1991; 44:880-888.
33. Bley MA, Simón JC, Estévez AG, Jiménez de Asúa L, Barañao JL. Effect of follicle-stimulating hormone on insulin-like growth factor-I-stimulated rat granulosa cell deoxyribonucleic acid synthesis. Endocrinology 1992; 131:1223-1229.
34. Lanuza GM, Fischman ML, Barañao JL. Growth promoting activity of oocytes on granulosa cells is decreased upon meiotic maturation. Dev Biol 1998; 197:129-139.
35. Dasmahapatra AK, Wimpee BA, Trewin AL, Hutz RJ. 2,3,7,8- Tetrachlorodibenzo-p-dioxin increases steady-state estrogen receptor-beta mRNA levels after CYP1A1 and CYP1B1 induction in rat granulosa cells in vitro. Mol Cell Endocrinol 2001; 182:39-48.
36. Barañao JL, Bley MA, Batista FD, Glikin GC. A DNA topoisomerase I inhibitor blocks the differentiation of rat granulosa cells induced by follicle-stimulating hormone. Biochem J 1991; 277:557-560.
37. Sokal RR, Rohlf FJ. Biometry. New York: WH Freeman and Co; 1995.
38. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996; 384:470-474.
39. Robker RR, Richards JS. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 1998; 12:924-940.
40. Davis BJ, Mccurdy EA, Miller BD, Lucier GW, Tritscher AM. Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Cancer Res 2000; 60:5414-5419.
41. Chaffin CL, Stouffer RL, Duffy DM. Gonadotropin and steroid regulation of steroid receptor and aryl hydrocarbon receptor messenger ribonucleic acid in macaque granulosa cells during the periovulatory interval. Endocrinology 1999; 140:4753-4760.
42. Spicer LJ, Hammond JM. Catecholestrogens inhibit proliferation and DNA synthesis of porcine granulosa cells in vitro: comparison with estradiol, 5 alpha-dihydrotestosterone, gonadotropins and catecholamines. Mol Cell Endocrinol 1989; 64:119-126.
43. Kellis JT Jr, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984; 225:1032-1034.
44. Campbell DR, Kurzer MS. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 1993; 46:381-388.
45. Pelissero C, Lenczowski MJ, Chinzi D, Davail-Cuisset B, Sumpter JP, Fostier A. Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem Mol Biol 1996; 57:215-223.
46. Matikainen T, Ferez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, Tilly JL. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet. 2001; 28(4):355-360.
47. Shiromizu K, Mattison DR. Murine oocyte destruction following intraovarian treatment with 3-methylcholanthrene or 7,12-dimethylbenz(a) anthracene: protection by alpha-napthoflavone. Teratog Carcinog Mutagen 1985; 5(6):463-472.
48. Navas JM, Segner H. Estrogen-mediated suppression of cytochrome P4501A (CYP1A) expression in rainbow trout hepatocytes: role of estrogen receptor. Chem Biol Interact 2001; 138:285-298.
49. Bemanian V, Male R, Goksoyr A. The aryl hydrocarbon receptor-mediated disruption of vitellogenin synthesis in the fish liver: Cross-talk between AHR- and ERalpha-signalling pathways. Comp Hepatol 2004; 3(1):2.
50. Hoivik D, Willett K, Wilson C, Safe S. Estrogen does not inhibit 2.3,7,8-tetrachlorodibenzo-p-dioxin mediated effects in MCF-7 and Hepa1c17 cells. J Biol Chem 1997; 272:30270-30274.
51. Safe S, Wormke M, Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J Mammary Gland Biol Neoplasia 2000; 5:295-306.
52. Kohle C, Hassepass I, Bock-Hennig BS, Walter Bock K, Poellinger L, McGuire J. Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells. Arch Biochem Biophys 2002; 402:172-179.
53. Beischlag TV, Perdew GH. ERα-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin inducible gene transcription. J Biol Chem 2005; 280:21607-21611. Published 18 April 2005, doi: 10.1074/jbc.C500090200.
54. Lösel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 2003; 4:46-56.
55. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, et al. Modulation of estrogen receptor signalling by association with the activated dioxin receptor. Nature 2003; 423:545-550.
56. Heath-Pagliuso S, Rogers WJ, Tullis K, Seidel SD, Cenijn PH, Brouwer A, Denison MS. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 1998; 37:11508-11515.
57. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA 3rd, Kalo T, Saeki K, Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001; 276:31475-31478.
58. Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, Sicinski RR, DeLuca HF. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci USA 2002; 99:14694-14699.
59. Schaldach CM, Riby J, Bjeldanes LF. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 1999; 38:7594-7600.
60. Sadek CM, Allen-Hoffmann BL. Cytochrome P4501A1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. J Biol Chem 1994; 269:16067-16074.
61. Mufti NA, Bleckwenn NA, Babish JG, Shuler ML. Possible involvement of the Ah receptor in the induction of cytochrome P-450IA1 under conditions of hydrodynamic shear in microcarrier-attached hepaloma cell lines. Biochem Biophys Res Commun 1995; 208:144-152.
62. Zaher H, Fernandez-Salguero PM, Letterio J, Sheikh MS, Fornace AJ, Roberts AB, Gonzalez FJ. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol Pharmacol 1998; 54:312-321.
63. Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS, Gonzalez FJ. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol 2000; 57:1056-1063.
64. Monk SA, Denison MS, Rice RH. Transient expression of CYP1A1 in rat epithelial cells cultured in suspension. Arch Biochem Biophys 2001; 393:154-162.
65. Leighton JK, Canning S, Guthrie HD, Hammond JM. Expression of cytochrome P450 1A1, an estrogen hydroxylase, in ovarian granulosa cells is developmentally regulated. J Steroid Biochem Mol Biol 1995; 52:351-356.
66. Dey A, Nebert DW. Markedly increased constitutive CYP1A1 mRNA levels in the fertilized ovum of the mouse. Biochem Biophys Res Commun 1998; 251:657-661.
67. Pocar P, Augustin R, Fischer B. Constitutive expression of CYP1A1 in bovine cumulus oocyte-complexes in vitro: mechanisms and biological implications. Endocrinology 2004; 145:1594-1601.
68. Yim S, Oh M, Choi SM, Park H. Inhibition of the MEK-1/p42 MAP kinase reduces aryl hydrocarbon receptor-DNA interactions. Biochem Biophys Res Commun 2004; 322:9-16.